WHO ICTRP trial

A study to see the additive epidural analgesic effect of two drugs…

CTRI/2020/05/025233 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2020/05/025233
Public title A study to see the additive epidural analgesic effect of two drugs dexmedetomidine & fentanyl
Scientific title An observational study between Fentanyl v/s Dexmedetomidine as adjuvant to epidural ropivacaine for postoperative analgesia in spine surgery
Primary sponsor Ptjnm medical college
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 1/ Phase 2
Countries India
Conditions Health Condition 1: G890- Central pain syndrome
Interventions Intervention1: Fentanyl v/s Dexmedetomidine: Fentanyl1mcg/ml with Ropivacaine 0.125%@ v/s dexmedetomidine 1mcg/ml with Ropivacaine 0.125%@ in epidural space as continuous infusion to be titrated.
Registration date May 18, 2020
Target size 30
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations